These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 7805746

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
    Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM.
    J Immunol; 1995 Jun 01; 154(11):5934-43. PubMed ID: 7538538
    [Abstract] [Full Text] [Related]

  • 3. Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7.
    Rudolf MP, Man S, Melief CJ, Sette A, Kast WM.
    Clin Cancer Res; 2001 Mar 01; 7(3 Suppl):788s-795s. PubMed ID: 11300474
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16.
    Chen L, Mizuno MT, Singhal MC, Hu SL, Galloway DA, Hellström I, Hellström KE.
    J Immunol; 1992 Apr 15; 148(8):2617-21. PubMed ID: 1313847
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer.
    Zehbe I, Kaufmann AM, Schmidt M, Hohn H, Maeurer MJ.
    J Immunother; 2007 Apr 15; 30(5):523-32. PubMed ID: 17589293
    [Abstract] [Full Text] [Related]

  • 8. Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
    Youde SJ, Dunbar PR, Evans EM, Fiander AN, Borysiewicz LK, Cerundolo V, Man S.
    Cancer Res; 2000 Jan 15; 60(2):365-71. PubMed ID: 10667589
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.
    Hara M, Matsueda S, Tamura M, Takedatsu H, Tanaka M, Kawano K, Mochizuki K, Kamura T, Itoh K, Harada M.
    Int J Oncol; 2005 Nov 15; 27(5):1371-9. PubMed ID: 16211234
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
    Frazer IH, Leippe DM, Dunn LA, Liem A, Tindle RW, Fernando GJ, Phelps WC, Lambert PF.
    Cancer Res; 1995 Jun 15; 55(12):2635-9. PubMed ID: 7540107
    [Abstract] [Full Text] [Related]

  • 14. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL.
    Clin Cancer Res; 2004 Oct 15; 10(20):6929-37. PubMed ID: 15501971
    [Abstract] [Full Text] [Related]

  • 15. Synthetic peptides induce a cytotoxic response against human papillomavirus type-18.
    Castellanos MR, Hayes RL, Maiman MA.
    Gynecol Oncol; 2001 Jul 15; 82(1):77-83. PubMed ID: 11426965
    [Abstract] [Full Text] [Related]

  • 16. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.
    Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, Roberts JS, Latimer JA, Moseley RP, Coleman N, Stanley MA, Sterling JC.
    Clin Cancer Res; 2003 Nov 01; 9(14):5205-13. PubMed ID: 14614000
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
    Xu Y, Zhu KJ, Chen XZ, Zhao KJ, Lu ZM, Cheng H.
    Arch Dermatol Res; 2008 Jun 01; 300(5):235-42. PubMed ID: 18299861
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.